Product Information
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $10.1945 per EA under NDC 69238209203. Its NADAC has been published 114 times since Jun 19, 2024.
FDA first approved this application on Aug 22, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Emtricitabine and Tenofovir Disoproxil Fumarate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB
Emtricitabine and Tenofovir Disoproxil FumarateStrength
100; 150 mg/1; mg/1
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
69238209203
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
4/22/2026
Active Ingredients
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA209721FDA Approved
8/22/2018
TE Code
AB
On Market Since
8/26/2018
Pharmacological Classes
Price Statistics
The NADAC for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB has been published 114 times since Jun 19, 2024, and over the history we have for it it has risen 81.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.1945 per EA |
|---|---|
| All-time high | $11.2736 (Jan 14, 2026) |
| All-time low | $4.1671 (Jul 17, 2024) |
| 52-week high | $11.2736 |
| 52-week low | $10.1523 |
| Median price | $9.9695 |
| Average price | $8.7732 |
| Largest weekly change | -26.0% (Jul 17, 2024) |
| Weeks tracked | 114 |
| Tracking since | Jun 19, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB, manufactured by Amneal Pharmaceuticals NY LLC, is $10.1945 per EA (NDC 69238209203), effective Aug 19, 2026.
How has the price of EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB changed over time?
Over the history we have for it, the NADAC for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB has risen 81.0%. It has been tracked across 114 weekly CMS publications since Jun 19, 2024.
What are the highest and lowest recorded NADAC prices for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB?
Since Jun 19, 2024, the NADAC for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB has ranged from a low of $4.1671 (Jul 17, 2024) to a high of $11.2736 (Jan 14, 2026), with a median of $9.9695 per EA.
Are there cheaper alternatives to EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB?
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB (NDC 69238209203) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.